Characterization of various deformable liposomes with metronidazole

Drug Development and Industrial Pharmacy

Volumn 39, Issue 3, 2013, Pages 481-488

  Vanić, Željka ^a   Hafner, Anita ^a   Bego, Margareta ^a   Škalko Basnet, Nataša ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Deformable liposomes; Entrapment; Metronidazole; Permeability; Surfactants; Vaginal application

Indexed keywords

ALCOHOL; DEOXYCHOLATE SODIUM; LIPOSOME; METRONIDAZOLE; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; SORBITAN OLEATE; SURFACTANT;

ARTICLE; CELL STRAIN CACO 2; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EGG; EPITHELIUM; FREEZE THAWING; PARTICLE SIZE;

ADMINISTRATION, INTRAVAGINAL; ANTI-INFECTIVE AGENTS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; LIPOSOMES; METRONIDAZOLE; MODELS, THEORETICAL; PARTICLE SIZE;

EID: 84873673832     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.670247     Document Type: Article

References (31)

1. Kirjavainen M, Urtti A, Jääskeläinen I, Suhonen TM, Paronen P, Valjakka-Koskela R et al. (1996). Interaction of liposomes with human skin in vitro-the influence of lipid composition and structure. Biochim Biophys Acta, 1304:179-189.
2. Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. (2007). Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm, 332:1-16.
3. Cevc G. (1996). Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst, 13:257-388.
4. Honeywell-Nguyen PL, Bowstra JA. (2005). Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today: Technol, 2:67-74.
5. Wain AM. (1998). Metronidazole vaginal gel 0.75% (MetroGel-Vaginal): a brief review. Infect Dis Obstet Gynecol, 6:3-7.
6. Bouckaert S, Temmerman M, Voorspoels J, Van Kets H, Remon JP, Dhont M. (1995). Preliminary efficacy study of a bioadhesive vaginal metronidazole tablet in the treatment of bacterial vaginosis. J Pharm Pharmacol, 47:970-971.
7. Garg S, Jambu L, Vermani K. (2007). Development of novel sustained release bioadhesive vaginal tablets of povidone iodine. Drug Dev Ind Pharm, 33:1340-1349.
8. Brown J, Hooper G, Kenyon CJ, Haines S, Burt J, Humphries JM et al. (1997). Spreading and retention of vaginal formulations in post-menopausal women as assessed by γ scintigraphy. Pharm Res, 14:1073-1078.
9. Perioli L, Ambrogi V, Venezia L, Giovagnoli S, Pagano C, Rossi C. (2009). Formulation studies of benzydamine mucoadhesive formulations for vaginal administration. Drug Dev Ind Pharm, 35:769-779.
10. Richardson JL, Whetstone J, Fischer AN, Watts P, Farraj F, Hinchcliffe M, Benedetti L, Illum L. (1996). γ-scintigraphy as a novel method to study the distribution and retention of a bioadhesive vaginal delivery system in sheep. J Control Release, 42:133-142.
11. Jain SK, Singh R, Sahu B. (1997). Development of a liposome based contraceptive system for intravaginal administration of progesterone. Drug Dev Ind Pharm, 23:827-830.
12. Ning M, Guo Y, Pan H, Chen X, Gu Z. (2005). Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole. Drug Dev Ind Pharm, 31: 375-383.
13. Pereira RRA, Bruschi, ML. (2011). Vaginal mucoadhesive drug delivery systems. Drug Dev Ind Pharm, 1-10 (Posted online on 15 Oct 2011).
14. Paveli Ž, Škalko N, Jalšenjak I. (1999). Liposomes containing drugs for treatment of vaginal infections. Eur J Pharm Sci, 8:345-351.
15. Paveli Ž, Škalko-Basnet N, Schubert R. (2001). Liposomal gels for vaginal drug delivery. Int J Pharm, 219:139-149.
16. Paveli Ž, Škalko-Basnet N, Jalšenjak I. (2004). Liposomal gel with chloramphenicol: characterisation and in vitro release. Acta Pharm, 54:319-330.
17. Paveli Ž, Škalko-Basnet N, Filipovi-Gri J, Martinac A, Jalšenjak I. (2005). Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. J Control Release, 106:34-43.
18. Paveli Ž, Škalko-Basnet N, Jalšenjak I. (2005). Characterisation and in vitro evaluation of bioadhesive liposome gels for local therapy of vaginitis. Int J Pharm, 301:140-148.
19. Wang L, Sassi AB, Patton D, Isaacs C, Moncla BJ, Gupta P, Rohan LC. (2011). Development of a liposome microbicide formulation for vaginal delivery of octylglycerol for HIV prevention. Drug Dev Ind Pharm, 1-10 (Posted online on 10 Dec 2011).
20. New RRC. (1990). Liposomes: A practical approach. Oxford: IRL Press, 33-104.
21. Hafner A, Lovri J, Voinovich D, Filipovi-Gri J. (2009). Melatoninloaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers. Int J Pharm, 381:205-213.
22. Choi MJ, Maibach HI. (2005). Elastic vesicles as topical/transdermal drug delivery systems. Int J Cosmet Sci, 27:211-221.
23. El Maghraby GM, Williams AC, Barry BW. (2000). Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm, 196:63-74.
24. Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. (2006). Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm, 322:60-66.
25. Kirby C, Gregoriadis G. (1984). Dehydration-rehydration vesicles: a simple method for high yield drug entrapment in liposomes. Bio/Technology, 2:979-984.
26. Katragadda S, Jain R, Kwatra D, Hariharan S, Mitra AK. (2008). Pharmacokinetics of amino acid ester prodrugs of acyclovir after oral administration: interaction with the transporters on Caco-2 cells. Int J Pharm, 362:93-101.
27. Mao S, Germershaus O, Fischer D, Linn T, Schnepf R, Kissel T. (2005). Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells. Pharm Res, 22:2058-2068.
28. Bonferoni MC, Sandri G, Rossi S, Ferrari F, Gibin S, Caramella C. (2008). Chitosan citrate as multifunctional polymer for vaginal delivery. Evaluation of penetration enhancement and peptidase inhibition properties. Eur J Pharm Sci, 33:166-176.
29. Graves TD, Condon M, Loucaidou M, Perry RJ. (2009). Reversible metronidazole-induced cerebellar toxicity in a multiple transplant recipient. J Neurol Sci, 285:238-240.
30. Kirjavainen M, Urtti A, Valjakka-Koskela R, Kiesvaara J, Mönkkönen J. (1999). Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci, 7: 279-286.
31. Magnusson BM, Runn P, Karlsson K, Koskinen L. (1997). Terpenes and ethanol enhance the transdermal permeation of the tripeptide thyrotropin releasing hormone in human epidermis. Int J Pharm, 157:113-121.